Armendáriz-Borunda, Juan <br/><br/>
Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment.  [electronic resource] 

 -  Journal of investigative medicine : the official publication of the American Federation for Clinical Research  Oct 2008 
 - 944-53 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1081-5589 
<br/><br/><label>Standard No.: </label>10.2310/JIM.0b013e3181891512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensinogen--genetics<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Base Sequence<br/>DNA Primers--genetics<br/>Female<br/>Hepatitis C--drug therapy<br/>Humans<br/>Liver Cirrhosis--drug therapy<br/>Liver Cirrhosis, Alcoholic--drug therapy<br/>Male<br/>Mexico<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Polymorphism, Genetic<br/>Pyridones--therapeutic use<br/>Transforming Growth Factor beta--genetics